Open Access Pub publishes peer-reviewed, free-to-read open-access articles. Showing
articles matching Ketamine — open any to read the full text,
or download the PDF or XML.
Li ShupengCorresponding author School of Chemical Biology and Biotechnology, Peking University Shenzhen Graduate School, Shenzhen, China
Ketamine’s potential as a fast-acting reagent to treat MDD, especially treatment-resistant depression has caught much attention recently. Although much has been learned about the biological mechanisms underlying ketamine’s effect, there are a few critical issues remained to be resolved. This mini review will briefly discuss several controversial issues that warrant further studies, regarding the molecular, physiological, psychopharmacological, and behavioral effects of ketamine. Understand how ketamine works as an anti-depressant will open the door to better understanding of MDD and its treatment.